Bae K, Ryoo NK, Ji YS, Bae JH, et al. A real-world experience with ranibizumab 0.5 mg initial intensive treatment for diabetic macular edema: 24-week outcomes of the RISING-K study. J Diabetes Complications 2025;40:109251.
PMID: 41468710